Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | BLM | P54132 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.65 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.65 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.65 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.65 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.65 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.65 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.65 |
| ▸ | HTR1A | P08908 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.65 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.65 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.65 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16353073 | 0.84 | ADRA2A (0.73) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL41537 | 0.84 | ADRA2A (1.00) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL2821312 | 0.82 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL2690356 | 0.82 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL16320883 | 0.82 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL41536 | 0.82 | MAPT (1.00) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL1643328 | 0.82 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL2303835 | 0.82 | ADRA2A (0.70) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL21356923 | 0.82 | ADRA2A (0.95) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL3788608 | 0.81 | CHRM5 (0.73) | ADRA2AADRA1AMAPTBLMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354930-A1 | IONIC LIQUID ENCAPSULATION OF NIR DYES FOR THE IMPROVEMENT OF BLOODSTAIN DETECTION | UNIV MISSISSIPPI (US) | 2025-11-20 | — | — | US | claimed |
| US-20220356272-A1 | PROCESSES FOR EXTRACTING AND PURIFYING CHITIN BY USING GREEN SOLVENTS | POLITECNICO DI MILANO (IT) | 2022-11-10 | — | — | US | claimed |
| EP-4034572-A1 | PROCESS FOR EXTRACTING AND PURIFYING CHITIN BY USING GREEN SOLVENTS | Politecnico di Milano (IT) | 2022-08-03 | — | — | EP | claimed |
| WO-2021059119-A1 | PROCESS FOR EXTRACTING AND PURIFYING CHITIN BY USING GREEN SOLVENTS | POLITECNICO DI MILANO (IT) | 2021-04-01 | — | — | WO | claimed |
| US-8187489-B1 | Biodegradable ionic liquids for aircraft deicing | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2012-05-29 | — | — | US | claimed |
| EP-2414476-A1 | IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS | E. I. du Pont de Nemours and Company (US) | 2012-02-08 | — | — | EP | claimed |
| US-20120011886-A1 | IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS | E. I. DU PONT DE NEMOURS AND COMPANY | 2012-01-19 | — | — | US | claimed |
| WO-2010117836-A1 | IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-10-14 | — | — | WO | claimed |
| US-20250354930-A1 | IONIC LIQUID ENCAPSULATION OF NIR DYES FOR THE IMPROVEMENT OF BLOODSTAIN DETECTION | UNIV MISSISSIPPI (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250354930-A1 | IONIC LIQUID ENCAPSULATION OF NIR DYES FOR THE IMPROVEMENT OF BLOODSTAIN DETECTION | UNIV MISSISSIPPI (US) | 2025-11-20 | — | — | US | disclosed |
| US-12441959-B2 | Composition containing organic ammonium salt | MIYOSHI OIL & FAT CO., LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-20250090437-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | MIYOSHI YUSHI KK (JP) | 2025-03-20 | — | — | US | disclosed |
| CN-113423470-B | Cosmetic compounding agent, cosmetic, and method for producing same | 三吉油脂株式会社 | 2024-07-09 | — | — | CN | disclosed |
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-01-18 | — | — | US | disclosed |
| WO-2011084765-A2 | PROCESS FOR THE SYNTHESIS OF CHOLINE SALTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-14 | — | — | WO | disclosed |
| WO-2010117836-A1 | IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-10-14 | — | — | WO | disclosed |
| US-7566686-B2 | Shale inhibition additive for oil/gas down hole fluids and methods for making and using same | CLEARWATER INTERNATIONAL, LLC (US) | 2009-07-28 | — | — | US | disclosed |
| US-20080039345-A1 | Shale inhibition additive for oil/gas down hole fluids and methods for making and using same | CLEARWATER INTERNATIONAL, L.L.C. | 2008-02-14 | — | — | US | disclosed |
| US-7268100-B2 | Shale inhibition additive for oil/gas down hole fluids and methods for making and using same | CLEARWATER INTERNATIONAL, LLC (US) | 2007-09-11 | — | — | US | disclosed |
| US-20060116296-A1 | Shale Inhibition additive for oil/gas down hole fluids and methods for making and using same | CLEARWATER INTERNATIONAL, L.L.C. | 2006-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | ADRA2A 1699/4885ADRA1A 1627/4885MAPT 170/4885 |
| US-12441959-B2 | Composition containing organic ammonium salt | SLC6A15, SLC38A7, SLC6A19 | ADRA2A 3034/4885ADRA1A 2644/4885MAPT 1640/4885 |
| US-20250090437-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | CUTA, HAT1, NACA | ADRA2A 4515/4885ADRA1A 4139/4885MAPT 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.